Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Portugal Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20051
20071
20091
20111
20121
20133
20142
20151
20162
20171
20182
20191
20214
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting6
Recruiting4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
Sanofi3
AbbVie2
Eli Lilly and Company2
Institut de Recherches Internationales Servier2
Pfizer2
Amgen1
Celcuity Inc1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis32
Breast Neoplasms10
Neoplasms10
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Melanoma4
Neoplasms by Site3
Prostatic Neoplasms3
Skin Diseases3
Brain Neoplasms2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.